Copyright © 2009 Antonio Brú et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. P. J. Edelson and Z. A. Cohn, “Peroxidase mediated mammalian cell cytotoxicity,” Journal of Experimental Medicine, vol. 138, no. 1, pp. 318–323, 1973. View at Scopus
2. R. A. Clark, S. J. Klebanoff, A. B. Einstein, and A. Fefer, “Peroxidase ${\text{H}}_2{\text{O}}_2$ halide system: cytotoxic effect on mammalian tumor cells,” Blood, vol. 45, no. 2, pp. 161–170, 1975. View at Scopus
3. J. J. Rinehart, P. Lange, B. J. Gormus, and M. E. Kaplan, “Human monocyte-induced tumor cell cytotoxicity,” Blood, vol. 52, no. 1, pp. 211–220, 1978. View at Scopus
4. G. M. Shaw, P. C. Levy, and A. F. LoBuglio, “Human monocyte antibody dependent cell mediated cytotoxicity to tumor cells,” Journal of Clinical Investigation, vol. 62, no. 6, pp. 1172–1180, 1978. View at Scopus
5. A. Slivka, A. F. LoBuglio, and S. J. Weiss, “A potential role for hypochlorous acid in granulocyte-mediated tumor cell cytotoxicity,” Blood, vol. 55, no. 2, pp. 347–350, 1980. View at Scopus
6. S. J. Weiss and A. Slivka, “Monocyte and granulocyte-mediated tumor cell destruction,” Journal of Clinical Investigation, vol. 69, no. 2, pp. 255–262, 1982. View at Scopus
7. F. Dallegri, F. Patrone, G. Frumento, and C. Sacchetti, “Antibody-dependent killing of tumor cells by polymorphonuclear leukocytes. Involvement of oxidative and nonoxidative mechanisms,” Journal of the National Cancer Institute, vol. 73, no. 2, pp. 331–339, 1984. View at Scopus
8. F. Dallegri, G. Frumento, A. Ballestrero, R. Goretti, and F. Patrone, “Relationship between antibody-dependent tumour cell lysis and primary granule exocytosis by human neutrophils,” Clinical and Experimental Immunology, vol. 70, no. 2, pp. 479–483, 1987. View at Scopus
9. A. Lichtenstein, M. Seelig, J. Berek, and J. Zighelboim, “Human neutrophil-mediated lysis of ovarian cancer cells,” Blood, vol. 74, no. 2, pp. 805–809, 1989. View at Scopus
10. M. Katano and M. Torisu, “Neutrophil-mediated tumor cell destruction in cancer ascites,” Cancer, vol. 50, no. 1, pp. 62–68, 1982. View at Scopus
11. D. J. Cameron, “A comparison of the cytotoxic potential in polymorphonuclear leukocytes obtained from normal donors and cancer patients,” Clinical Immunology and Immunopathology, vol. 28, no. 1, pp. 115–124, 1983. View at Scopus
12. F. Lozupone, F. Luciani, M. Venditti, et al., “Murine granulocytes control human tumor growth in SCID mice,” International Journal of Cancer, vol. 87, no. 4, pp. 569–573, 2000. View at Publisher · View at Google Scholar · View at Scopus
13. F. Dallegri, A. Ballestrero, L. Ottonello, and F. Patrone, “Defective antibody-dependent tumour cell lysis by neutrophils from cancer patients,” Clinical and Experimental Immunology, vol. 77, no. 1, pp. 58–61, 1989. View at Scopus
14. Y. Midorikawa, T. Yamashita, and F. Sendo, “Modulation of the immune response to transplanted tumors in rats by selective depletion of neutrophils in vivo using a monoclonal antibody: abrogation of specific transplantation resistance to chemical carcinogen-induced syngeneic tumors by selective depletion of neutrophils in vivo,” Cancer Research, vol. 50, no. 19, pp. 6243–6247, 1990. View at Scopus
15. M. J. Alvarez, F. Prada, E. Salvatierra, et al., “Secreted protein acidic and rich in cysteine produced by human melanoma cells modulates polymorphonuclear leukocyte recruitment and antitumor cytotoxic capacity,” Cancer Research, vol. 65, no. 12, pp. 5123–5132, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
16. G. Biozzi, O. G. Ribeiro, A. Saran, et al., “Effect of genetic modification of acute inflammatory responsiveness on tumorigenesis in the mouse,” Carcinogenesis, vol. 19, no. 2, pp. 337–346, 1998. View at Publisher · View at Google Scholar · View at Scopus
17. D. A. Maria, O. G. Ribeiro, K. F. Pizzocaro, et al., “Resistance to melanoma metastases in mice selected for high acute inflammatory response,” Carcinogenesis, vol. 22, no. 2, pp. 337–342, 2001. View at Scopus
18. O. G. Ribeiro, D. A. Maria, S. Adriouch, et al., “Convergent alteration of granulopoiesis, chemotactic activity, and neutrophil apoptosis during mouse selection for high acute inflammatory response,” Journal of Leukocyte Biology, vol. 74, no. 4, pp. 497–506, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
19. O. G. Ribeiro, W. H. Cabrera, D. A. Maria, et al., “Genetic selection for high acute inflammatory response confers resistance to lung carcinogenesis in the mouse,” Experimental Lung Research, vol. 31, no. 1, pp. 105–116, 2005. View at Publisher · View at Google Scholar · View at Scopus
20. J. R. Ostberg, B. R. Ertel, and J. A. Lanphere, “An important role for granulocytes in the thermal regulation of colon tumor growth,” Immunological Investigations, vol. 34, no. 3, pp. 259–272, 2005. View at Publisher · View at Google Scholar · View at Scopus
21. N. Agrawal, C. Bettegowda, I. Cheong, et al., “Bacteriolytic therapy can generate a potent immune response against experimental tumors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 42, pp. 15172–15177, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
22. F. Avogadri, C. Martinoli, L. Petrovska, et al., “Cancer immunotherapy based on killing of Salmonella-infected tumor cells,” Cancer Research, vol. 65, no. 9, pp. 3920–3927, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
23. H. Suttmann, J. Riemensberger, G. Bentien, et al., “Neutrophil granulocytes are required for effective Bacillus Calmette-Guérin immunotherapy of bladder cancer and orchestrate local immune responses,” Cancer Research, vol. 66, no. 16, pp. 8250–8257, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
24. C. Maletzki, M. Linnebacher, B. Kreikemeyer, and J. Emmrich, “Pancreatic cancer regression by intratumoural injection of live Streptococcus pyogenes in a syngeneic mouse model,” Gut, vol. 57, no. 4, pp. 483–491, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
25. Z. Cui, M. C. Willingham, A. M. Hicks, et al., “Spontaneous regression of advanced cancer: identification of a unique genetically determined, age-dependent trait in mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 11, pp. 6682–6687, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
26. A. M. Hicks, G. Riedlinger, M. C. Willingham, et al., “Transferable anticancer innate immunity in spontaneous regression/complete resistance mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 20, pp. 7753–7758, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
27. A. M. Hicks, M. C. Willingham, W. Du, C. S. Pang, L. J. Old, and Z. Cui, “Effector mechanisms of the anti-cancer immune responses of macrophages in SR/CR mice,” Cancer Immunity, vol. 6, pp. 1–9, 2006. View at Scopus
28. M. Jaganjac, M. Poljak-Blazi, K. Zarkovic, R. J. Schaur, and N. Zarkovic, “The involvement of granulocytes in spontaneous regression of Walker 256 carcinoma,” Cancer Letters, vol. 260, no. 1-2, pp. 180–186, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
29. P. Musiani, A. Allione, A. Modica, et al., “Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-$\gamma$, IFN-$\alpha$, and TNF-$\alpha$,” Laboratory Investigation, vol. 74, no. 1, pp. 146–157, 1996. View at Scopus
30. B. M. Babior, “Phagocytes and oxidative stress,” American Journal of Medicine, vol. 109, no. 1, pp. 33–44, 2000. View at Publisher · View at Google Scholar · View at Scopus
31. A. K. Lichtenstein, T. Ganz, M. E. Selsted, and R. I. Lehrer, “Synergistic cytolysis mediated by hydrogen peroxide combined with peptide defensins,” Cellular Immunology, vol. 114, no. 1, pp. 104–116, 1988. View at Scopus
32. K. P. M. Van Kessel, J. A. G. Van Strijp, H. J. Van Kats-Renaud, L. A. M. Miltenburg, A. C. Fluit, and J. Verhoef, “Uncoupling of oxidative and non-oxidative mechanisms in human granulocyte-mediated cytotoxicity: use of cytoplasts and cells from chronic granulomatous disease patient,” Journal of Leukocyte Biology, vol. 48, no. 4, pp. 359–366, 1990. View at Scopus
33. M.-B. Hevin, B. Friguet, and R. M. Fauve, “Inflammation and anti-tumor resistance. V. Production of a cytostatic factor following cooperation of elicited polymorphonuclear leukocytes and macrophages,” International Journal of Cancer, vol. 46, no. 3, pp. 533–538, 1990. View at Publisher · View at Google Scholar · View at Scopus
34. A. L. Kindzelskii and H. R. Petty, “Early membrane rupture events during neutrophil-mediated antibody-dependent tumor cell cytolysis,” Journal of Immunology, vol. 162, no. 6, pp. 3188–3192, 1999. View at Scopus
35. M. Zivkovic, M. Poljak-Blazi, G. Egger, S. B. Sunjic, R. J. Schaur, and N. Zarkovic, “Oxidative burst and anticancer activities of rat neutrophils,” BioFactors, vol. 24, no. 1–4, pp. 305–312, 2005. View at Scopus
36. H. Horner, C. Frank, C. Dechant, et al., “Intimate cell conjugate formation and exchange of membrane lipids precede apoptosis induction in target cells during antibody-dependent, granulocyte-mediated cytotoxicity,” Journal of Immunology, vol. 179, no. 1, pp. 337–345, 2007. View at Scopus
37. A. Brú, J. M. Pastor, I. Fernaud, I. Brú, S. Melle, and C. Berenguer, “Super-rough dynamics on tumor growth,” Physical Review Letters, vol. 81, no. 18, pp. 4008–4011, 1998. View at Scopus
38. A. Brú, S. Albertos, J. L. Subiza, J. L. García-Asenjo, and I. Brú, “The universal dynamics of tumor growth,” Biophysical Journal, vol. 85, no. 5, pp. 2948–2961, 2003. View at Scopus
39. A. Brú, S. Albertos, J. L. García-Asenjo, and I. Brú, “Pinning of tumoral growth by enhancement of the immune response,” Physical Review Letters, vol. 92, no. 23, Article ID 238101, 4 pages, 2004. View at Publisher · View at Google Scholar · View at Scopus
40. A. Brú, S. Albertos, F. García-Hoz, and I. Brú, “Regulation of neutrophilia by granulocyte colony-stimulating factor: a new cancer therapy that reversed a case of terminal hepatocellular carcinoma,” Journal of Clinical Research, vol. 8, no. 9–13, pp. 9–13, 2005. View at Scopus
41. Y. B. Su, A. J. Vickers, M. J. Zelefsky, et al., “Double-blind, placebo-controlled, randomized trial of granulocyte-colony stimulating factor during postoperative radiotherapy for squamous head and neck cancer,” Cancer Journal, vol. 12, no. 3, pp. 182–188, 2006. View at Publisher · View at Google Scholar · View at Scopus
42. B. I. Rini, L. Fong, V. Weinberg, B. Kavanaugh, and E. J. Small, “Clinical and immunological characteristics of patients with serologic progression of prostate cancer achieving long-term disease control with granulocyte-macrophage colony-stimulating factor,” Journal of Urology, vol. 175, no. 6, pp. 2087–2091, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
43. U. Bottoni, P. Bonaccorsi, V. Devirgiliis, et al., “Complete remission of brain metastases in three patients with stage IV melanoma treated with BOLD and G-CSF,” Japanese Journal of Clinical Oncology, vol. 35, no. 9, pp. 507–513, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
44. T. A. Springer, “Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration,” Annual Review of Physiology, vol. 57, pp. 827–872, 1995. View at Scopus
45. J. Solá, L. Vila, L. Puig, and J. M. de Moragas, “Metabolism of exogenous arachidonic acid by polymorphonuclear leukocytes from psoriatic patients,” Archives of Dermatological Research, vol. 283, no. 2, pp. 77–80, 1991. View at Scopus
46. P. M. Davison, K. Bensch, and M. A. Karasek, “Isolation and growth of endothelial cells from the microvessels of the newborn human foreskin in cell culture,” Journal of Investigative Dermatology, vol. 75, no. 4, pp. 316–321, 1980. View at Scopus
47. K. Sakamoto, T. Masuda, S. Mita, et al., “Interleukin-8 is constitutively and commonly produced by various human carcinoma cell lines,” International Journal of Clinical & Laboratory Research, vol. 22, no. 1–4, pp. 216–219, 1992. View at Publisher · View at Google Scholar · View at Scopus
48. H. Schaider, M. Oka, T. Bogenrieder, et al., “Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8,” International Journal of Cancer, vol. 103, no. 3, pp. 335–343, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
49. S. K. Ahuja and P. M. Murphy, “The CXC chemokines growth-regulated oncogene (GRO) $\alpha$, GRO$\beta$, GRO$\gamma$, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor,” Journal of Biological Chemistry, vol. 271, no. 34, pp. 20545–20550, 1996. View at Publisher · View at Google Scholar · View at Scopus
50. H. Petering, O. Götze, D. Kimmig, R. Smolarski, A. Kapp, and J. Elsner, “The biologic role of interlekin-8:functional analysis and expression of CXCR1 and CXCR2 on human eosinophils,” Blood, vol. 93, pp. 694–702, 1999.
51. A. Wuyts, P. Proost, J.-P. Lenaerts, A. Ben-Baruch, J. Van Damme, and J. M. Wang, “Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neuhrophil attractant-78,” European Journal of Biochemistry, vol. 255, no. 1, pp. 67–73, 1998. View at Scopus
52. D. Cilloni, G. Martinelli, F. Messa, M. Baccarani, and G. Saglio, “Nuclear factor $\kappa$B as a target for new drug development in myeloid malignancies,” Haematologica, vol. 92, no. 9, pp. 1224–1229, 2007. View at Publisher · View at Google Scholar · View at Scopus
53. C. Van Waes, “Nuclear factor-$\kappa$B in development, prevention, and therapy of cancer,” Clinical Cancer Research, vol. 13, no. 4, pp. 1076–1082, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
54. A. E. Koch, P. J. Polverini, S. L. Kunkel, et al., “Interleukin-8 as a macrophage-derived mediator of angiogenesis,” Science, vol. 258, no. 5089, pp. 1798–1801, 1992. View at Scopus
55. D. R. Smith, P. J. Polverini, S. L. Kunkel, et al., “Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma,” Journal of Experimental Medicine, vol. 179, no. 5, pp. 1409–1415, 1994. View at Scopus
56. J. M. Wang, G. Taraboletti, K. Matsushima, J. Van Damme, and A. Mantovani, “Induction of haptotactic migration of melanoma cells by neutrophil activating protein/interleukin-8,” Biochemical and Biophysical Research Communications, vol. 169, no. 1, pp. 165–170, 1990. View at Publisher · View at Google Scholar · View at Scopus
57. R. K. Singh, M. Gutman, R. Radinsky, C. D. Bucana, and I. J. Fidler, “Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice,” Cancer Research, vol. 54, no. 12, pp. 3242–3247, 1994. View at Scopus
58. C. L. Galligan and B. L. Coomber, “Effects of human IL-8 isoforms on bovine neutrophil function in vitro,” Veterinary Immunology and Immunopathology, vol. 74, no. 1-2, pp. 71–85, 2000. View at Publisher · View at Google Scholar · View at Scopus
59. B. Metzner, M. Barbisch, F. Parlow, E. Kownatzki, I. Schraufstatter, and J. Norgauer, “Interleukin-8 and GRO$\alpha$ prime human neutrophils for superoxide anion production and induce up-regulation of N-formyl peptide-receptors,” Journal of Investigative Dermatology, vol. 104, no. 5, pp. 789–791, 1995. View at Scopus
60. N. Mukaida, “Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation,” International Journal of Hematology, vol. 72, no. 4, pp. 391–398, 2000. View at Scopus
61. J. M. Cook-Mills and T. L. Deem, “Active participation of endothelial cells in inflammation,” Journal of Leukocyte Biology, vol. 77, no. 4, pp. 487–495, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
62. L. Yang, R. M. Froio, T. E. Sciuto, A. M. Dvorak, R. Alon, and F. W. Luscinskas, “ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-$\alpha$-activated vascular endothelium under flow,” Blood, vol. 106, no. 2, pp. 584–592, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
63. T. M. Carlos and J. M. Harlan, “Leukocyte-endothelial adhesion molecules,” Blood, vol. 84, no. 7, pp. 2068–2101, 1994. View at Scopus
64. A. B. Van Spriel, J. H. W. Leusen, M. van Egmond, et al., “Mac-1 (CD11b/CD18) is essential for Fc receptor-mediated neutrophil cytotoxicity and immunologic synapse formation,” Blood, vol. 97, no. 8, pp. 2478–2486, 2001. View at Publisher · View at Google Scholar · View at Scopus
65. A. B. Van Spriel, H. H. van Ojik, A. Bakker, M. J. H. Jansen, and J. G. J. van de Winkel, “Mac-1 (CD11b/CD18) is crucial for effective fc receptor-mediated immunity to melanoma,” Blood, vol. 101, no. 1, pp. 253–258, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
66. A. Mantovani, P. Romero, A. K. Palucka, and F. M. Marincola, “Tumour immunity: effector response to tumour and role of the microenvironment,” The Lancet, vol. 371, no. 9614, pp. 771–783, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
67. E. Di Carlo, G. Forni, P. Lollini, M. P. Colombo, A. Modesti, and P. Musiani, “The intriguing role of polymorphonuclear neutrophils in antitumor reactions,” Blood, vol. 97, no. 2, pp. 339–345, 2001. View at Publisher · View at Google Scholar · View at Scopus
68. E. Di Carlo, G. Forni, and P. Musiani, “Neutrophils in the antitumoral immune response,” Chemical Immunology and Allergy, vol. 83, pp. 182–203, 2003. View at Scopus
69. O. J. Finn, “Cancer immunology,” New England Journal of Medicine, vol. 358, no. 25, pp. 2704–2715, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
70. E. Wang, A. Worschech, and F. M. Marincola, “The immunologic constant of rejection,” Trends in Immunology, vol. 29, no. 6, pp. 256–262, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
71. J. C. Souto, L. Vila, and A. Brú, “Polymorphonuclear neutrophils and cancer. Intense and sustained neutrophilia as a treatment against solid tumors,” Medicinal Research Reviews, December 4 [Epub ahead of print], 2009.